Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.

Saved in:

Bibliographic Details
Title:	Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.
Authors:	Nguyen N; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany., Min Y; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany., Rivière J; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany., van der Garde M; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany., Ghosh S; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America., Bartos LM; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Bassermann F; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany., Azhdarinia A; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, United States of America., Weber WA; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Götze KS; Department of Medicine III, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany., Kossatz S; Department of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University Munich, Munich, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.; Department of Chemistry, School of Natural Sciences, Technical University Munich, Munich, Germany.
Source:	Theranostics [Theranostics] 2025 May 25; Vol. 15 (13), pp. 6497-6515. Date of Electronic Publication: 2025 May 25 (Print Publication: 2025).
Publication Type:	Journal Article
Journal Info:	Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1838-7640
DOI:	10.7150/thno.113354